Gynecologic Cancer News

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in the part of the gene that is central to BRCA2 function, according to study results.

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term mortality rates among people with advanced cancer, according to results of a cohort study.

Approximately one in three patients diagnosed with cancer in Ontario presented to an ED in the 90 days preceding their diagnosis, according to findings published in Canadian Medical Association Journal.

Fewer than half of women who tested positive for HPV with negative cytological findings returned for a surveillance co-test within 1 year as recommended, yet more than half of those who received testing had HPV persistence or progression.

Few researchers can claim to be a pioneer in their field quite like Teresa K. Woodruff, PhD.

Breast cancer survivors who harbor BRCA gene mutation are at elevated risk for second primary cancers, according to study results.

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.

Incorporating digital screening tools and patient education into obstetrics and gynecology care may improve hereditary cancer risk assessment and genetic testing completion, according to study results published in Obstetrics & Gynecology.